{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:38:40Z","timestamp":1785404320914,"version":"3.56.0"},"reference-count":99,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ASHE"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pharmacy Benefit Managers (PBMs) are contracted by health plans, employers, and government programs to manage pharmacy and prescription drug benefits. They maintain drug formularies, process and pay pharmacy claims, establish and manage pharmacy networks, and negotiate prices with manufacturers and pharmacies. Despite PBMs\u2019 role in cost management, their lack of transparency and complex administrative processes can delay treatment and increase out-of-pocket costs, affecting vulnerable populations like those in pharmacy deserts. These factors influence healthcare delivery for persons living with human immunodeficiency virus, Hepatitis C Virus, and other conditions. Herein, we describe PBM practices and their impacts on infectious diseases patients and highlight mitigation strategies to facilitate timely and equitable medication access.<\/jats:p>","DOI":"10.1017\/ash.2025.10277","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:12:16Z","timestamp":1768291936000},"source":"Crossref","is-referenced-by-count":0,"title":["What should infectious diseases clinicians know about pharmacy benefit managers and their impact on our patients?"],"prefix":"10.1017","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-3313","authenticated-orcid":false,"given":"Karan","family":"Raja","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05vt9qd57","id-type":"ROR","asserted-by":"publisher"}],"name":"Clara Maass Medical Center"},{"id":[{"id":"https:\/\/ror.org\/05vt9qd57","id-type":"ROR","asserted-by":"publisher"}],"name":"Rutgers, The State University of New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Acbo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05vt9qd57","id-type":"ROR","asserted-by":"publisher"}],"name":"Rutgers, The State University of New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto R.","family":"Jimenez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05vt9qd57","id-type":"ROR","asserted-by":"publisher"}],"name":"Rutgers, The State University of New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Silverman","sequence":"additional","affiliation":[{"name":"Prime Healthcare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Golia","sequence":"additional","affiliation":[{"name":"New York-Presbyterian - Weill Cornell Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1495-1964","authenticated-orcid":false,"given":"Alyssa Joy","family":"Ford","sequence":"additional","affiliation":[{"name":"Barnabas Health Medical Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Nori","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"S2732494X25102775_ref86","unstructured":"86. How the UnitedHealthcare Gold Card program helps modernize prior authorization, 4 September 2025. uhc.com\/news-articles\/newsroom\/gold-card. Accessed June 19, 2025"},{"key":"S2732494X25102775_ref94","unstructured":"94. Mavyret cost, 2025. https:\/\/www.mavyret.com\/cost. Accessed July 17, 2025"},{"key":"S2732494X25102775_ref35","unstructured":"35. APRETUDE (cabotegravir 200 mg\/mL) access, 2025. https:\/\/apretudehcp.com\/access-and-support\/. Accessed June 3, 2025"},{"key":"S2732494X25102775_ref97","unstructured":"97. MerckHelps, 2025. https:\/\/www.merckhelps.com\/DIFICID%20Tablets. Accessed July 20, 2025"},{"key":"S2732494X25102775_ref9","unstructured":"9. CVS Health. Pharmacy benefit manager. https:\/\/www.cvshealth.com\/services\/prescription-drug-coverage\/pharmacy-benefits-management.html. Accessed April 22, 2025"},{"key":"S2732494X25102775_ref79","unstructured":"79. Murphy, A. Trump threatens 200% tariffs on pharmaceuticals. Beckers Hospital Review 2025. https:\/\/www.beckershospitalreview.com\/pharmacy\/trump-threatens-200-tariffs-on-pharmaceuticals\/. Accessed July 31, 2025"},{"key":"S2732494X25102775_ref33","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0001037328.00912.f7"},{"key":"S2732494X25102775_ref52","unstructured":"52. Paxlovid [package insert]. New York, NY: Pfizer Inc; 2025."},{"key":"S2732494X25102775_ref43","unstructured":"43. Center for Health Law and Policy Innovation of Harvard Law School and National Viral Hepatitis Roundtable. State of Hepatitis C Medicaid Access, 2025 https:\/\/stateofhepc.org\/. Accessed June 3, 2025"},{"key":"S2732494X25102775_ref92","unstructured":"92. PAN Foundation, 2025. https:\/\/www.panfoundation.org\/disease-funds\/hiv-treatment-and-prevention\/. Accessed July 19, 2025"},{"key":"S2732494X25102775_ref1","first-page":"99","article-title":"A primer on brand-name prescriptions drug reimbursement in the United States","volume":"30","author":"Hernandez","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"S2732494X25102775_ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197702032960505"},{"key":"S2732494X25102775_ref71","unstructured":"71. Abelson, R , Robbins, R . The Powerful Companies Driving Local Drugstores Out of Business. The New York Times, 2024. www.nytimes.com\/2024\/10\/19\/business\/drugstores-closing-pbm-pharmacy.html?campaign_id=29&emc=edit_up_20241021&instance_id=137417&nl=the-upshot&regi_id=60161387&segment_id=180991&user_id=3e0200aeb84abbcf6b2bb392d92dfb53. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref76","unstructured":"76. Patient Protector, 2025. https:\/\/patientprotector.us\/. Accessed June 13, 2025"},{"key":"S2732494X25102775_ref23","unstructured":"23. Wendling, M , Halpert, M. Killing of insurance CEO reveals simmering anger at US health system. BBC, December 7, 2024. https:\/\/www.bbc.com\/news\/articles\/cm2eeeep0npo. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref93","unstructured":"93. Patient Advocate Foundation. https:\/\/www.patientadvocate.org\/connect-with-services\/copay-relief\/. Accessed July 19, 2025"},{"key":"S2732494X25102775_ref66","unstructured":"66. Cervantes, F . Where are Rite Aid locations closing across the US? What to know amid bankruptcy. USA Today, 2025. https:\/\/www.usatoday.com\/story\/money\/2025\/05\/07\/rite-aid-stores-closing\/83502576007\/. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref96","unstructured":"96. Support Path, 2025. https:\/\/www.mysupportpath.com\/patients. Accessed July 17, 2025"},{"key":"S2732494X25102775_ref16","unstructured":"16. Federal Trade Commission. FTC Launches Inquiry into Prescription Drug Middlemen Industry, 2022. https:\/\/www.ftc.gov\/news-events\/news\/press-releases\/2022\/06\/ftc-launches-inquiry-prescription-drug-middlemen-industry. Accessed April 21, 2025."},{"key":"S2732494X25102775_ref48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab549"},{"key":"S2732494X25102775_ref11","unstructured":"11. National Community Pharmacists Association (NCPA). PBM Reform Resources. https:\/\/ncpa.org\/pbm. Accessed April 22, 2025"},{"key":"S2732494X25102775_ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.3804"},{"key":"S2732494X25102775_ref46","unstructured":"46. Express Scripts Medicare (PDP), 2025 Formulary (List of Covered Drugs or \u201cDrug List\u201d). https:\/\/www.express-scripts.com\/pdf\/egwp\/F0PA3P5A_508.pdf. Accessed June 3, 2025"},{"key":"S2732494X25102775_ref8","unstructured":"8. Lichtenstein, E. Pharmacy benefit managers: what they are and why they matter. Agent Sync, 2024. https:\/\/agentsync.io\/blog\/insurance-101\/pharmacy-benefit-managers-what-they-are-and-why-they-matter. Accessed April 22, 2025"},{"key":"S2732494X25102775_ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.5699"},{"key":"S2732494X25102775_ref55","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7416a1"},{"key":"S2732494X25102775_ref87","unstructured":"87. MyAbbVie assist program. Accessed 21 July 2025. https:\/\/www.abbvie.com\/patients\/patient-support\/patient-assistance\/available-programs.html"},{"key":"S2732494X25102775_ref89","unstructured":"89. ViiV healthcare patient assistance program (PAP), 2025. https:\/\/gskpaf.org\/viiv\/prescription-medicine-patient-assistance\/. Accessed July 19, 2025"},{"key":"S2732494X25102775_ref15","unstructured":"15. Schmid, CE. Complaint on substandard & discriminatory HIV medication coverage & plan design by Community Health Choice Texas. HIV+HEP Policy Institute, September 26, 2023. https:\/\/hivhep.org\/testimony-comments-letters\/complaint-on-substandard-discriminatory-hiv-medication-coverage-plan-design-by-community-health-choice-texas\/#:~:text=*%20Biktarvy%20(bictegravir\/emtricitabine\/tenofovir%20alafenamide)%20*%20Dovato%20(dolutegravir\/lamivudine),lamivudine%20+%20tenofovir%20disoproxil%20or%20tenofovir%20alafenamide. Accessed 15 October 2"},{"key":"S2732494X25102775_ref38","unstructured":"38. CDC. Figure 3.1 \u2013 acute hepatitis C: Number of cases & estimated infections., 2022 Viral Hepatitis Surveillance Report.https:\/\/www.cdc.gov\/hepatitis-surveillance-2022\/hepatitis-c\/figure-3-1.html. Published 2025. Accessed May 12, 2025"},{"key":"S2732494X25102775_ref54","unstructured":"54. Access, 2025. https:\/\/paxlovid.pfizerpro.com\/access-resources\/access. Accessed June 24, 2025"},{"key":"S2732494X25102775_ref36","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2023.00808"},{"key":"S2732494X25102775_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0489-1"},{"key":"S2732494X25102775_ref34","unstructured":"34. Access & acquisition, 2025.\u00a0https:\/\/cabenuvahcp.com\/access-and-acquisition\/access-and-acquisition\/. Accessed June 3, 2025"},{"key":"S2732494X25102775_ref58","unstructured":"58. CDC. RSV Immunization Guidance for Infants and Young Children 2025. https:\/\/www.cdc.gov\/rsv\/hcp\/vaccine-clinical-guidance\/infants-young-children.html. Published 2025. Accessed October 26, 2024"},{"key":"S2732494X25102775_ref82","unstructured":"82. Trish, EE , Van Nuys, K. \u201cHow to save patients money by ending one type of insurance coverage\u201d. The Washington Post, March 28, 2023.\u00a0https:\/\/www.washingtonpost.com\/opinions\/2023\/03\/28\/generic-drugs-health-insurance-cost\/. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref91","unstructured":"91. ADAP Directory, 2025. https:\/\/adap.directory\/. Accessed 19 July 2025"},{"key":"S2732494X25102775_ref61","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7241e1"},{"key":"S2732494X25102775_ref68","unstructured":"68. Garbato, D. Unjust pharmacy deserts. Drug Store News, May 9, 2025. https:\/\/drugstorenews.com\/unjust-pharmacy-deserts. Accessed May 13, 2025"},{"key":"S2732494X25102775_ref21","unstructured":"21. Potter, W . I Was a Health Insurance Executive. What I Saw Made Me Quit. The New York Times, 2024. https:\/\/www.nytimes.com\/2024\/12\/18\/opinion\/health-insurance-united-ceo-shooting.html. Accessed April 21, 2025"},{"key":"S2732494X25102775_ref53","unstructured":"53. Aetna medicare silverScript choice (PDP) formulary, 2025. Accessed July 15, 2025. https:\/\/www.onlyhealthinsurance.com\/wp-content\/uploads\/2024\/10\/2025-Aetna-SilverScript-Choice-formulary.pdf"},{"key":"S2732494X25102775_ref22","unstructured":"22. Tufekci, Z . The Rage and Glee That Followed a CEOs Killing Should Ring All Alarms. The New York Times, 2024. https:\/\/www.nytimes.com\/2024\/12\/06\/opinion\/united-health-care-ceo-shooting.html. Accessed April 21, 2025"},{"key":"S2732494X25102775_ref41","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319"},{"key":"S2732494X25102775_ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06370-1"},{"key":"S2732494X25102775_ref29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae479"},{"key":"S2732494X25102775_ref17","unstructured":"17. Murphy, HT. The truth about Amazon\u2019s really cheap generic drugs. Slate, January 28, 2023. https:\/\/slate.com\/business\/2023\/01\/amazon-rxpass-cost-plus-drug-generics-mark-cuban-cheap.html. Accessed May 12, 2025"},{"key":"S2732494X25102775_ref20","unstructured":"20. Gulati, R , Beard, A. The UnitedHealthcare CEO Shooting Should be a Turning Point for Corporate America. Harvard Business Review, December, 12 2024. https:\/\/hbr.org\/2024\/12\/the-unitedhealthcare-ceo-shooting-should-be-a-turning-point-for-corporate-america. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref47","unstructured":"47. Center for Drug Evaluation, Research. Expanded access to clofazimine. U.S. Food and Drug Administration. https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/expanded-access-clofazimine. Published 2023. Accessed June 3, 2025"},{"key":"S2732494X25102775_ref32","unstructured":"32. Hepatitis B virus\/HIV coinfection. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/hepatitis-b-virus-hiv-coinfection. Accessed May 12, 2025"},{"key":"S2732494X25102775_ref59","unstructured":"59. CDC. Vaccines for Children (VFC) Program Eligibility. Centers for Disease Control and Prevention, 2025. https:\/\/www.cdc.gov\/vaccines-for-children\/hcp\/program-eligibility\/index.html. Accessed July 20, 2025"},{"key":"S2732494X25102775_ref70","unstructured":"70. Hamstra, M. Retail pharmacy is adapting to meet local needs. Drug Store News, 3 October 2025. https:\/\/drugstorenews.com\/retail-pharmacy-adapting-meet-local-needs. Accessed November 13, 2025"},{"key":"S2732494X25102775_ref37","doi-asserted-by":"publisher","DOI":"10.36469\/jheor.2023.56928"},{"key":"S2732494X25102775_ref39","unstructured":"39. CDC. Table 3.7 \u2013 hepatitis C: Death rates by jurisdiction. 2022 Viral Hepatitis Surveillance Report. https:\/\/www.cdc.gov\/hepatitis-surveillance-2022\/hepatitis-c\/table-3-7.html. Published 2025. Accessed May 12, 2025"},{"key":"S2732494X25102775_ref74","unstructured":"74. National Community Pharmacists Association. Spread Pricing Explained for Pharmacists, 2025. https:\/\/ncpa.org\/spread-pricing-101. Accessed 26 October 2025"},{"key":"S2732494X25102775_ref78","unstructured":"78. Murphy, A. Tariffs delayed again: 5 things to know. Becker\u2019s Hospital Review 2025. https:\/\/www.beckershospitalreview.com\/supply-chain\/tariffs-delayed-again-5-things-to-know\/. Accessed July 31, 2025"},{"key":"S2732494X25102775_ref80","unstructured":"80. Murphy, A. Supply chain challenges in 2025: 5 things to know. Becker\u2019s Hospital Review 2025https:\/\/www.beckershospitalreview.com\/supply-chain\/supply-chain-challenges-in-2025-5-things-to-know\/. Accessed July 31, 2025"},{"key":"S2732494X25102775_ref85","unstructured":"85. Complete Drug List (Formulary 00025002) 2025, AARP Medicare Advantage from UnitedHealthcare. _2MW0R_AAUT25HM0255400_000.pdf. Accessed August 10, 2025"},{"key":"S2732494X25102775_ref72","unstructured":"72. Khawaja, Z , Kazi, A. It\u2019s High Time States Banned PBM-Owned Pharmacies. Medpage Today 2025. https:\/\/www.medpagetoday.com\/opinion\/second-opinions\/117028?xid=nl_secondopinion_2025-08-19&mh=c3ea53f175358a76025ae59728f6203e&zdee=gAAAAABm4wmblJr7Fq-ZTVxKbMTn0A6l60jUGJY_L0UQlyEzMzfjPCk9zGJAct_sbsB1VjClKSQoqircjCZFsq3SH7kA8rvXR0Tn-xgRcy-CtUFPqoxGWWg%3D&utm_source=Sailthru&utm_medium=email&utm_campaign=SecondOpinions_081925. Accessed August 20, 2025"},{"key":"S2732494X25102775_ref56","unstructured":"56. Beyfortus\u00ae (nirsevimab-alip) cost and coverage, 2025. https:\/\/www.beyfortus.com\/about\/cost-and-coverage. Accessed June 24, 2025"},{"key":"S2732494X25102775_ref57","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2025-073923"},{"key":"S2732494X25102775_ref81","unstructured":"81. Formulary, Horizon BCBS of NJ 2025. https:\/\/www.myprime.com\/content\/dam\/prime\/memberportal\/WebDocs\/2025\/Formularies\/HIM\/2025_NJ_3T_HealthInsuranceMarketplace.pdf. Accessed August 12, 2025"},{"key":"S2732494X25102775_ref88","unstructured":"88. Patient Assistance Programs and Co-payment Assistance Programs: Resources for Accessing HIV Treatment. HIV.gov. https:\/\/www.hiv.gov\/hiv-basics\/staying-in-hiv-care\/hiv-treatment\/paying-for-hiv-care-and-treatment\/assistance. Accessed July 19, 2025"},{"key":"S2732494X25102775_ref95","unstructured":"95. Saving on Epclusa, 2025. https:\/\/www.epclusa.com\/saving-on-epclusa. Accessed July 17, 2025"},{"key":"S2732494X25102775_ref50","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf335"},{"key":"S2732494X25102775_ref98","unstructured":"98. Merck Connect, 2025. https:\/\/www.merckconnect.com\/services\/request-samples-vouchers-coupons\/. Accessed July 20, 2025"},{"key":"S2732494X25102775_ref99","unstructured":"99. Fein, Adam J. The 2025 economic report on U.S. Pharmacies and Pharmacy Benefit Managers, Drug Channels Institute, 2025.\u00a0https:\/\/drugchannelsinstitute.com\/products\/industry_report\/pharmacy\/. Accessed August 5, 2025"},{"key":"S2732494X25102775_ref67","unstructured":"67. Constantino, AK. Walgreens to go private in roughly $10 billion deal with Sycamore Partners. CNBC, March 6, 2025. https:\/\/www.cnbc.com\/2025\/03\/06\/walgreens-to-go-private-in-10-billion-deal-with-sycamore-partners.html#:\u223c:text=Walgreens%20said%20it%20inked%20a,company%2C%20which%20began%20in%201927. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref19","unstructured":"19. Semuels, A. They hated health insurance. So they started paying for each other\u2019s care. Time, March 20, 2025. Accessed April 14, 2025 https:\/\/time.com\/7269608\/crowdhealth-health-sharing\/#"},{"key":"S2732494X25102775_ref31","unstructured":"31. Second Interim Staff Report. Specialty Generic Drugs: A Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers. Federal Trade Commission, 2025"},{"key":"S2732494X25102775_ref73","unstructured":"73. Vrbin, T. Whooping cough, tuberculosis cases spiked in Arkansas last year, Department of Health reports. Arkansas Advocate 9 January 2025>. https:\/\/arkansasadvocate.com\/2025\/01\/09\/whooping-cough-tuberculosis-cases-spiked-in-arkansas-last-year-department-of-health-reports\/#:~:text=1-,Whooping%20cough%2C%20tuberculosis%20cases%20spiked%20in%20Arkansas%20last%20year%2C%20Department,on%20its%20own%2C%20said%20Dr. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref2","unstructured":"2. Frieden, J. Why are drug prices so high? PBMs are only part of the answer, say GOP advisors. MedPage Today, August 5, 2025. https:\/\/www.medpagetoday.com\/publichealthpolicy\/washington-watch\/116843?xid=nl_mpt_DHE_2025-08-05&mh=c3ea53f175358a76025ae59728f6203e&zdee=gAAAAABm4wmblJr7Fq-ZTVxKbMTn0A6l60jUGJY_L0UQlyEzMzfjPCk9zGJAct_sbsB1VjClKSQoqircjCZFsq3SH7kA8rvXR0Tn-xgRcy-CtUFPqoxGWWg%3D&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%20Evening%20-%20Randomized%202025-08-05&utm_term=NL_Daily_DHE_dual-gmail-definition. Accessed August 12, 2025"},{"key":"S2732494X25102775_ref13","unstructured":"13. Ornstein, C , Thomas, K. When Buying Prescription Drugs, Some Pay More With Insurance than without it. ProPublica, December 9, 2017. https:\/\/www.propublica.org\/article\/when-buying-prescription-drugs-some-pay-more-with-insurance-than-without-it. Accessed October 15, 2025"},{"key":"S2732494X25102775_ref14","unstructured":"14. Robbins, R , Abelsen, R . The Opaque Industry Secretly Inflating Prices for Prescription Drugs. The New York Times. https:\/\/www.nytimes.com\/2024\/06\/21\/business\/prescription-drug-costs-pbm.html. Accessed October 31, 2024."},{"key":"S2732494X25102775_ref30","unstructured":"30. SUNLENCA\u00ae (lenacapavir), 2026. https:\/\/www.sunlencahcp.com\/. Accessed January 7, 2026"},{"key":"S2732494X25102775_ref62","unstructured":"62. Cost & coverage, 2025. https:\/\/www.abrysvo.com\/cost-and-coverage. Accessed June 24, 2025"},{"key":"S2732494X25102775_ref5","volume-title":"The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers","author":"Fein","year":"2024"},{"key":"S2732494X25102775_ref27","unstructured":"27. Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection, 2024. https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncacal-decision-memo.aspx?proposed=N&ncaid=310. Accessed May 12, 2025"},{"key":"S2732494X25102775_ref60","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7332e1"},{"key":"S2732494X25102775_ref10","unstructured":"10. PCMA. The Value of PBMs: PBMs are Committed to Helping Patients. Pharmaceutical Care Management Association. http:\/\/pcmanet.org\/value-of-pbms\/. Accessed May 6, 2025"},{"key":"S2732494X25102775_ref18","unstructured":"18. Sax, P. Why We Have Antibiotic Shortages and Price Hikes \u2014 And What One Very Enterprising Doctor Did in Response. HIV and ID Observations, April 15, 2024. https:\/\/blogs.jwatch.org\/hiv-id-observations\/index.php\/why-we-have-antibiotic-shortages-and-price-hikes-and-what-one-very-enterprising-doctor-did-in-response\/2024\/10\/08\/. Accessed April 15, 2025"},{"key":"S2732494X25102775_ref64","unstructured":"64. Rosenthal, E. What one expectant mom\u2019s effort to get an RSV shot says about health policy. KFF Health News. https:\/\/kffhealthnews.org\/news\/article\/health-202-rsv-vaccine-policy-roadblocks\/. Published 2023. Accessed June 24, 2025"},{"key":"S2732494X25102775_ref63","unstructured":"63. Coverage, 2025. https:\/\/arexvyhcp.com\/practice-education\/coverage\/?cc=ps_QAFRKIR1XQ2158288&mcm=330009&gclsrc=aw.ds&&gclid=CjwKCAjw9uPCBhATEiwABHN9K3pRuPitlPhpQuno4eS_AXrN-3D7_IUiUliwJ5MSPby8hPO2WqjKOBoCKQ8QAvD_BwE&gad_source=1&gad_campaignid=22579687338&gbraid=0AAAAApk5DZ1OO2AYPm__N14DezWS-RVJx. Accessed June 24, 2025"},{"key":"S2732494X25102775_ref65","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.0171"},{"key":"S2732494X25102775_ref28","unstructured":"28. Prevention of acquisition of HIV: Preexposure prophylaxis. Published, August 22, 2023. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis. Accessed May 12, 2025"},{"key":"S2732494X25102775_ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.0302"},{"key":"S2732494X25102775_ref69","unstructured":"69. Pharmacy benefit companies 101: a primer. Pharmaceutical Care Management Association. March 16, 2023. https:\/\/www.pcmanet.org\/rx-research-corner\/pharmacy-benefit-companies-101-a-primer\/03\/16\/2023\/. Accessed May 12, 2025"},{"key":"S2732494X25102775_ref75","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2025.38"},{"key":"S2732494X25102775_ref77","unstructured":"77. Dyrda, L. One Big Beautiful Bill Act fallout: Health system CEOs brace for change. Beckers Hospital Review 2025. https:\/\/www.beckershospitalreview.com\/hospital-management-administration\/one-big-beautiful-bill-act-fallout-health-system-ceos-brace-for-change\/. Accessed July 31, 2025"},{"key":"S2732494X25102775_ref83","doi-asserted-by":"publisher","DOI":"10.26099\/fsgq-y980"},{"key":"S2732494X25102775_ref42","unstructured":"42. CVS Caremark Value Formulary - 2025. caremark.com. https:\/\/www.caremark.com\/portal\/asset\/Value_Formulary.pdf. Accessed May 21, 2025"},{"key":"S2732494X25102775_ref24","unstructured":"24. Pharmaceutical Strategies Group. 2024 Pharmacy Benefit Manager Customer Satisfaction Report. Dallas, TX: PSG. psgconsults.com\/research."},{"key":"S2732494X25102775_ref26","unstructured":"26. Turner, N , Hamasaki, T , Evans, S , et al. Dalbavancin is non-inferior to standard of care therapy for complicated Staphylococcus aureus bacteremia (SAB). ESCMID Global. abstract 00812. 2024"},{"key":"S2732494X25102775_ref7","first-page":"341","article-title":"Managing the pharmacy benefit: the formulary system","volume":"26","author":"Goldberg","year":"2020","journal-title":"J Managed Care Pharm"},{"key":"S2732494X25102775_ref84","unstructured":"84. House Committee on Oversight and Accountability Staff. The Role of Pharmacy Benefit Managers in Prescription Drug Markets, 2024. https:\/\/oversight.house.gov\/wp-content\/uploads\/2024\/07\/PBM-Report-FINAL-with-Redactions.pdf. Accessed January 7, 2026"},{"key":"S2732494X25102775_ref49","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab898"},{"key":"S2732494X25102775_ref51","unstructured":"51. OptumRx. 2025 Select standard formulary. https:\/\/www.optum.com\/content\/dam\/noindex-resources\/consumers\/pdfs\/guides\/070125-select-standard-booklet.pdf. Accessed June 3, 2025"},{"key":"S2732494X25102775_ref4","volume-title":"Current Population Reports, P60-281, Health Insurance Coverage in the United States: 2022, U.S","author":"Keisler-Starkey","year":"2023"},{"key":"S2732494X25102775_ref45","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa241"},{"key":"S2732494X25102775_ref90","unstructured":"90. Gilead advancing access, 2025. https:\/\/www.gileadadvancingaccess.com\/. Accessed July 19, 2025"}],"container-title":["Antimicrobial Stewardship &amp; Healthcare Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2732494X25102775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:12:28Z","timestamp":1768291948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2732494X25102775\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"alternative-id":["S2732494X25102775"],"URL":"https:\/\/doi.org\/10.1017\/ash.2025.10277","relation":{},"ISSN":["2732-494X"],"issn-type":[{"value":"2732-494X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e18"}}